JP7109446B2 - 幹細胞/前駆支持細胞の自己複製を誘導するための1h-ピロール-2,5-ジオン化合物およびその使用方法 - Google Patents
幹細胞/前駆支持細胞の自己複製を誘導するための1h-ピロール-2,5-ジオン化合物およびその使用方法 Download PDFInfo
- Publication number
- JP7109446B2 JP7109446B2 JP2019536012A JP2019536012A JP7109446B2 JP 7109446 B2 JP7109446 B2 JP 7109446B2 JP 2019536012 A JP2019536012 A JP 2019536012A JP 2019536012 A JP2019536012 A JP 2019536012A JP 7109446 B2 JP7109446 B2 JP 7109446B2
- Authority
- JP
- Japan
- Prior art keywords
- cells
- alkyl
- halo
- group
- lgr5
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
- A61K31/5513—1,4-Benzodiazepines, e.g. diazepam or clozapine
- A61K31/5517—1,4-Benzodiazepines, e.g. diazepam or clozapine condensed with five-membered rings having nitrogen as a ring hetero atom, e.g. imidazobenzodiazepines, triazolam
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0046—Ear
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Medicinal Preparation (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662441060P | 2016-12-30 | 2016-12-30 | |
| US62/441,060 | 2016-12-30 | ||
| US201762484282P | 2017-04-11 | 2017-04-11 | |
| US62/484,282 | 2017-04-11 | ||
| PCT/US2017/067885 WO2018125746A1 (en) | 2016-12-30 | 2017-12-21 | 1h-pyrrole-2,5-dione compounds and methods of using them to induce self-renewal of stem/progenitor supporting cells |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2020503340A JP2020503340A (ja) | 2020-01-30 |
| JP2020503340A5 JP2020503340A5 (cg-RX-API-DMAC7.html) | 2021-02-04 |
| JP7109446B2 true JP7109446B2 (ja) | 2022-07-29 |
Family
ID=60972503
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019536012A Expired - Fee Related JP7109446B2 (ja) | 2016-12-30 | 2017-12-21 | 幹細胞/前駆支持細胞の自己複製を誘導するための1h-ピロール-2,5-ジオン化合物およびその使用方法 |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US11066419B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP3562827A1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP7109446B2 (cg-RX-API-DMAC7.html) |
| KR (1) | KR20190104359A (cg-RX-API-DMAC7.html) |
| CN (1) | CN110392686A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2017386417B2 (cg-RX-API-DMAC7.html) |
| BR (1) | BR112019013388A2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3048220A1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL267601A (cg-RX-API-DMAC7.html) |
| MX (1) | MX390321B (cg-RX-API-DMAC7.html) |
| SG (1) | SG10201910821XA (cg-RX-API-DMAC7.html) |
| WO (1) | WO2018125746A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10213511B2 (en) | 2016-03-02 | 2019-02-26 | Frequency Therapeutics, Inc. | Thermoreversible compositions for administration of therapeutic agents |
| US10201540B2 (en) | 2016-03-02 | 2019-02-12 | Frequency Therapeutics, Inc. | Solubilized compositions for controlled proliferation of stem cells / generating inner ear hair cells using GSK3 inhibitors: I |
| AU2017386417B2 (en) | 2016-12-30 | 2022-07-14 | Frequency Therapeutics, Inc. | 1H-pyrrole-2,5-dione compounds and methods of using them to induce self-renewal of stem/progenitor supporting cells |
| EP3837350A1 (en) | 2018-08-17 | 2021-06-23 | Frequency Therapeutics, Inc. | Compositions and methods for generating hair cells by upregulating pi3k |
| WO2020037326A1 (en) | 2018-08-17 | 2020-02-20 | Frequency Therapeutics, Inc. | Compositions and methods for generating hair cells by downregulating foxo |
| WO2020037323A1 (en) | 2018-08-17 | 2020-02-20 | Frequency Therapeutics, Inc. | Compositions and methods for generating hair cells by upregulating jag-1 |
| BR112021006092A2 (pt) | 2018-10-02 | 2021-07-20 | Frequency Therapeutics, Inc. | composições farmacêuticas que compreendem agentes terapêuticos óticos e métodos relacionados |
| CN114174496A (zh) | 2019-02-08 | 2022-03-11 | 频率医疗公司 | 用于通过抑制表观遗传靶标来产生毛细胞的组合物和方法 |
| WO2020163812A1 (en) | 2019-02-08 | 2020-08-13 | Frequency Therapeutics, Inc. | Valproic acid compounds and wnt agonists for treating ear disorders |
| WO2020163813A1 (en) | 2019-02-08 | 2020-08-13 | Frequency Therapeutics, Inc. | Taz activators and wnt agonists for treating ear disorders |
| MX2021012258A (es) | 2019-04-08 | 2022-01-04 | Frequency Therapeutics Inc | Combinacion de chir99021 y acido valproico para tratar la perdida auditiva. |
| CN111205231B (zh) * | 2020-02-24 | 2021-12-17 | 浙江大学 | 作为ankrd22抑制剂的先导化合物及其应用 |
| US12371463B2 (en) | 2021-04-20 | 2025-07-29 | University of Pittsburgh—of the Commonwealth System of Higher Education | Methods and compositions for treatment of antibiotic-resistant bacterial infections |
| EP4337321A4 (en) * | 2021-05-12 | 2025-03-19 | University of Pittsburgh - of the Commonwealth System of Higher Education | MANIPULATED ANTIMICROBIAL PEPTIDES AND THEIR USE |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2003076442A1 (en) | 2002-03-05 | 2003-09-18 | Eli Lilly And Company | Purine derivatives as kinase inhibitors |
| WO2009006043A2 (en) | 2007-07-02 | 2009-01-08 | Eli Lilly And Company | Potentiation of cancer chemotherapy by 7-(2,5-dihydro-4-imidazo [1,2-a]pyrine-3-yl-2,5-dioxo-ih-pyrrol-3-yl)-9-fluoro-1,2,3,4 tetrahydro-2-(1-piperidinyl-carbonyd-pyrrolo[3,2,1-jk][1,4]benzodiazepine |
| WO2013126805A2 (en) | 2012-02-24 | 2013-08-29 | Fate Therapeutics, Inc. | Small molecule compounds to treat hearing loss |
| WO2016037016A1 (en) | 2014-09-03 | 2016-03-10 | The Brigham And Women's Hospital, Inc. | Compositions, systems, and methods for generating inner ear hair cells for treatment of hearing loss |
Family Cites Families (166)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5059591B1 (en) | 1983-05-26 | 2000-04-25 | Liposome Co Inc | Drug preparations of reduced toxicity |
| US5571714A (en) | 1988-12-22 | 1996-11-05 | Celtrix Pharmaceuticals, Inc. | Monoclonal antibodies which bind both transforming growth factors β1 and β2 and methods of use |
| GB8904161D0 (en) * | 1989-02-23 | 1989-04-05 | Hoffmann La Roche | Substituted pyrroles |
| US6124449A (en) | 1990-06-11 | 2000-09-26 | Nexstar Pharmaceuticals, Inc. | High affinity TGFβ nucleic acid ligands and inhibitors |
| US5731144A (en) | 1990-06-11 | 1998-03-24 | Nexstar Pharmaceuticals, Inc. | High affinity TGFβ nucleic acid ligands |
| US5731424A (en) | 1990-06-11 | 1998-03-24 | Nexstar Pharmaceuticals, Inc. | High affinity TGFβ nucleic acid ligands and inhibitors |
| US5561163A (en) | 1990-08-31 | 1996-10-01 | Deprenyl Animal Health, Inc. | Treating hearing loss with deprenyl |
| US5421818A (en) | 1993-10-18 | 1995-06-06 | Inner Ear Medical Delivery Systems, Inc. | Multi-functional inner ear treatment and diagnostic system |
| GB9601081D0 (en) | 1995-10-06 | 1996-03-20 | Cambridge Antibody Tech | Specific binding members for human transforming growth factor beta;materials and methods |
| US5837681A (en) | 1996-02-23 | 1998-11-17 | Amgen Inc. | Method for treating sensorineural hearing loss using glial cell line-derived neurotrophic factor (GDNF) protein product |
| US6593290B1 (en) | 1996-11-01 | 2003-07-15 | Genentech, Inc. | Treatment of inner ear hair cells |
| US6045528A (en) | 1997-06-13 | 2000-04-04 | Intraear, Inc. | Inner ear fluid transfer and diagnostic system |
| US6639051B2 (en) | 1997-10-20 | 2003-10-28 | Curis, Inc. | Regulation of epithelial tissue by hedgehog-like polypeptides, and formulations and uses related thereto |
| US6177434B1 (en) | 1997-12-16 | 2001-01-23 | The United States Of America As Represented By The Secretary Of The Navy | Prevention or reversal of sensorineural hearing loss (SNHL) through biologic mechanisms |
| US6806358B1 (en) | 1997-12-16 | 2004-10-19 | University Of California San Diego | Peptide inhibitor of TGF-β growth factors |
| AU760046B2 (en) | 1998-02-27 | 2003-05-08 | United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The | Disubstituted lavendustin a analogs and pharmaceutical compositions comprising the analogs |
| GB9809869D0 (en) | 1998-05-09 | 1998-07-08 | Medical Res Council | Inhibition of protein kinases |
| US6184226B1 (en) | 1998-08-28 | 2001-02-06 | Scios Inc. | Quinazoline derivatives as inhibitors of P-38 α |
| ES2146552B1 (es) | 1998-11-24 | 2001-04-16 | Inst Cientifico Tecnol Navarra | Peptidos inhibidores de tgf/31 |
| US6291516B1 (en) | 1999-01-13 | 2001-09-18 | Curis, Inc. | Regulators of the hedgehog pathway, compositions and uses related thereto |
| AU4206200A (en) | 1999-04-05 | 2000-10-23 | Adherex Technologies Inc. | Compounds and methods for stimulating beta-catenin mediated gene expression and differentiation |
| US6492497B1 (en) | 1999-04-30 | 2002-12-10 | Cambridge Antibody Technology Limited | Specific binding members for TGFbeta1 |
| WO2001044247A2 (en) * | 1999-12-16 | 2001-06-21 | Eli Lilly And Company | Agents and methods for the treatment of proliferative diseases |
| JP2001275095A (ja) | 2000-03-27 | 2001-10-05 | Sony Corp | 通信方法、通信サービス装置、通信端末装置および通信システム |
| WO2001074344A2 (en) | 2000-03-30 | 2001-10-11 | Curis, Inc. | Small organic molecule regulators of cell proliferation |
| US7115653B2 (en) | 2000-03-30 | 2006-10-03 | Curis, Inc. | Small organic molecule regulators of cell proliferation |
| US20050070578A1 (en) | 2000-03-30 | 2005-03-31 | Baxter Anthony David | Small organic molecule regulators of cell proliferation |
| US6683108B1 (en) | 2000-03-30 | 2004-01-27 | Curis, Inc. | Agonists of hedgehog signaling pathways and uses related thereto |
| US6683192B2 (en) | 2000-03-30 | 2004-01-27 | Curis, Inc. | Small organic molecule regulators of cell proliferation |
| DE60129799T2 (de) | 2000-03-31 | 2008-04-30 | The General Hospital Corp., Boston | Verfahren zur steigerung des haarwuchses durch wnt polypeptid |
| DE60129222T2 (de) | 2000-05-11 | 2008-03-06 | Consejo Superior de Investigaciónes Científicas | Heterocyclischen inhibitoren von glycogen synthase kinase gsk-3 |
| US6509318B1 (en) | 2000-09-29 | 2003-01-21 | The Regents Of The University Of California | TGF-B inhibitors and methods |
| US6887996B2 (en) | 2000-12-01 | 2005-05-03 | Guilford Pharmaceuticals Inc. | Compounds and their use |
| BR0116468A (pt) | 2000-12-08 | 2004-06-29 | Ortho Mcneil Pharm Inc | Compostos de pirrolina substituìda por indazolila como inibidores de cinase |
| US20050287128A1 (en) | 2001-05-18 | 2005-12-29 | Sirna Therapeutics, Inc. | RNA interference mediated inhibition of TGF-beta and TGF-beta receptor gene expression using short interfering nucleic acid (siNA) |
| US20050227936A1 (en) | 2001-05-18 | 2005-10-13 | Sirna Therapeutics, Inc. | RNA interference mediated inhibition of TGF-beta and TGF-beta receptor gene expression using short interfering nucleic acid (siNA) |
| SI1397364T1 (sl) | 2001-05-24 | 2007-12-31 | Lilly Co Eli | Novi pirolni derivati kot farmacevtske uäśinkovine |
| US20030028905A1 (en) | 2001-07-31 | 2003-02-06 | Petra Knaus | Mutant forms of the TGF-beta type II receptor which bind all TGF-beta isoforms |
| IL161662A0 (en) | 2001-11-01 | 2004-09-27 | Janssen Pharmaceutica Nv | Heteroaryl amines as glycogen synthase kinase 3 beta inhibitors (gsk3 inhibitors) |
| SE0200979D0 (sv) | 2002-03-28 | 2002-03-28 | Astrazeneca Ab | New compounds |
| US20040006030A1 (en) | 2002-07-02 | 2004-01-08 | Isis Pharmaceuticals Inc. | Antisense modulation of TGF-beta 2 expression |
| JP2005530800A (ja) | 2002-05-15 | 2005-10-13 | スミスクライン・ビーチャム・コーポレイション | ベンゾオキサジンおよびベンゾオキサジノン置換トリアゾール |
| AU2003229305A1 (en) | 2002-05-17 | 2003-12-02 | Scios, Inc. | TREATMENT OF FIBROPROLIFERATIVE DISORDERS USING TGF-Beta INHIBITORS |
| US7190468B2 (en) | 2002-07-17 | 2007-03-13 | Hewlett-Packard Development Company, L.P. | Background document rendering system and method |
| EP1539748A1 (en) | 2002-07-31 | 2005-06-15 | Smithkline Beecham Corporation | 2-phenylpyridin-4-yl derivatives as alk5 inhibitors |
| EP1739087A1 (en) | 2002-08-02 | 2007-01-03 | Vertex Pharmaceuticals Incorporated | Pyrazole compositions useful as inhibitors of gsk-3 |
| UA80296C2 (en) | 2002-09-06 | 2007-09-10 | Biogen Inc | Imidazolopyridines and methods of making and using the same |
| WO2004026871A1 (en) | 2002-09-17 | 2004-04-01 | Eli Lilly And Company | Novel pyrazolopyridine derivatves as pharmaceutical agents |
| KR20050057441A (ko) | 2002-09-18 | 2005-06-16 | 화이자 프로덕츠 인코포레이티드 | 전환 성장 인자 억제제로서의 신규한 아이소티아졸 및아이속사졸 화합물 |
| JP2006502236A (ja) | 2002-09-18 | 2006-01-19 | ファイザー・プロダクツ・インク | 形質転換成長因子(tgf)阻害剤としてのトリアゾール誘導体 |
| AU2003301407B2 (en) | 2002-10-15 | 2010-04-22 | Irm Llc | Compositions and methods for inducing osteogenesis |
| WO2004047818A2 (en) | 2002-11-22 | 2004-06-10 | Scios, Inc. | USE OF TFG-β INHIBITORSTO COUNTERACT PATHOLOGIC CHANGES IN THE LEVEL OR FUNCTION OF STEROID/THYROID RECEPTORS |
| WO2004058720A2 (en) * | 2002-12-24 | 2004-07-15 | Biofocus Plc | Compound libraries of 1,3,5-substitute indazole derivatives as compounds for targetting compounds capable of binding to the g-protein coupled receptor |
| JP2006516603A (ja) | 2003-01-27 | 2006-07-06 | ファイザー・プロダクツ・インク | イソチアゾール誘導体 |
| DE602004014347D1 (de) | 2003-03-12 | 2008-07-24 | Millennium Pharm Inc | Chinazolin-derivate als tgf-beta-inhibitoren |
| EP1608631A4 (en) | 2003-03-28 | 2008-08-20 | Scios Inc | BICYCLIC PYRIMIDININHIBITORS OF TGF BETA |
| ES2389258T3 (es) | 2003-06-17 | 2012-10-24 | Millennium Pharmaceuticals, Inc. | Composiciones y métodos para inhibir TGF-s |
| GB0316756D0 (en) | 2003-07-17 | 2003-08-20 | Bp Chem Int Ltd | Process |
| WO2005009287A2 (en) | 2003-07-21 | 2005-02-03 | University Of Maryland, Baltimore | Drug delivery to the inner ear and methods of using same |
| SG145713A1 (en) | 2003-08-13 | 2008-09-29 | Univ Illinois | SILENCING OF TGFss TYPE II RECEPTOR EXPRESSION BY SIRNA |
| JP4688680B2 (ja) | 2003-10-28 | 2011-05-25 | 独立行政法人理化学研究所 | TGF−β情報伝達経路阻害剤 |
| US8673634B2 (en) | 2003-11-13 | 2014-03-18 | Massachusetts Eye & Ear Infirmary | Method for the treatment of hearing loss |
| GB0327908D0 (en) | 2003-12-02 | 2004-01-07 | Neuropharma Sa | GSK-3 inhibitors isolated from marine organisms |
| CA2551524A1 (en) | 2003-12-24 | 2005-07-21 | Scios, Inc. | Treatment of malignant gliomas with tgf-beta inhibitors |
| US7368445B2 (en) | 2004-03-01 | 2008-05-06 | Eli Lilly And Company | Fused pyrazole derivatives as TGF-β signal transduction inhibitors for the treatment of fibrosis and neoplasms |
| AR048335A1 (es) | 2004-03-24 | 2006-04-19 | Chugai Pharmaceutical Co Ltd | Agentes terapeuticos para trastornos del oido interno que contienen un antagonista de il- 6 como un ingrediente activo |
| WO2005115527A2 (en) | 2004-05-24 | 2005-12-08 | Auris Medical, Llc. | Combined otic aspirator and medication dispenser |
| GB0418328D0 (en) | 2004-08-17 | 2004-09-22 | Imp College Innovations Ltd | Cancer methods and medicaments |
| JP2007176795A (ja) | 2004-08-18 | 2007-07-12 | Univ Nihon | TGF−β遺伝子発現抑制剤 |
| WO2006034207A2 (en) | 2004-09-17 | 2006-03-30 | Vanderbilt University | Use of gsk3 inhibitors in combination with radiation therapies |
| CA2597098C (en) | 2005-02-08 | 2016-08-02 | Steven R. Ledbetter | Antibodies to tgfbeta |
| RS51826B (sr) * | 2005-02-09 | 2012-02-29 | Arqule Inc. | Maleimid derivati, farmaceutske kompozicije i postupak lečenja kancera |
| GB0505970D0 (en) | 2005-03-23 | 2005-04-27 | Univ Edinburgh | Culture medium containing kinase inhibitor, and uses thereof |
| CN101189234B (zh) | 2005-03-25 | 2011-08-17 | 泰博特克药品有限公司 | Hcv的杂二环抑制剂 |
| ES2931949T3 (es) | 2005-03-29 | 2023-01-05 | Univ Pennsylvania | Minoxidilo para generar nuevos folículos pilosos y tratar la calvicie |
| DK1864132T3 (da) | 2005-03-31 | 2012-07-16 | Stemnion Inc | Fra amnion stammende cellesammensætninger, fremgangsmåder til fremstilling deraf og anvendelser deraf |
| UA92608C2 (en) | 2005-06-30 | 2010-11-25 | Янссен Фармацевтика Н.В. | Cyclic anilino - pyridinotriazines as gsk-3 inhibitors |
| CA2616196C (en) | 2005-07-22 | 2012-08-21 | Eli Lilly And Company | A pyridin quinolin substituted pyrrolo [1,2-b] pyrazole monohydrate as tgf-beta inhibitor |
| EP1749523A1 (en) | 2005-07-29 | 2007-02-07 | Neuropharma, S.A. | GSK-3 inhibitors |
| AU2005337776B2 (en) | 2005-10-24 | 2013-01-31 | Proyecto De Biomedicina Cima, S.L. | Use of TGF-Beta1 inhibitor peptides in the preparation of an immune response modulating agent |
| US7951845B2 (en) | 2006-01-19 | 2011-05-31 | The Regents Of The University Of Michigan | Composition and method of treating hearing loss |
| ITMI20060181A1 (it) | 2006-02-03 | 2007-08-04 | Univ Padova | Modulatori del tgf-b e loro uso |
| TW200800203A (en) | 2006-03-08 | 2008-01-01 | Astrazeneca Ab | New use |
| WO2007109097A2 (en) | 2006-03-16 | 2007-09-27 | Alnylam Pharmaceuticals, Inc. | RNAi MODULATION OF TGF-BETA AND THERAPEUTIC USES THEREOF |
| ES2641528T3 (es) | 2006-06-27 | 2017-11-10 | Shiseido Company, Limited | Masa celular capaz de servir como estructura de tipo órgano primitivo compuesta por una diversidad de tipos de células de origen somático |
| TWM303325U (en) | 2006-07-13 | 2006-12-21 | Everlight Electronics Co Ltd | Light emitting diode package |
| CA2661334C (en) | 2006-08-23 | 2011-11-29 | Pfizer Products Inc. | Pyrimidone compounds as gsk-3 inhibitors |
| JP5138253B2 (ja) | 2006-09-05 | 2013-02-06 | 東京エレクトロン株式会社 | アニール装置 |
| US20090214474A1 (en) | 2006-11-01 | 2009-08-27 | Barbara Brooke Jennings | Compounds, methods, and treatments for abnormal signaling pathways for prenatal and postnatal development |
| WO2008057469A1 (en) | 2006-11-02 | 2008-05-15 | Wyeth | Small organic molecule regulators of cell proliferation |
| WO2008057497A2 (en) | 2006-11-02 | 2008-05-15 | Curis, Inc. | Small organic molecule regulators of cell proliferation |
| US8273747B2 (en) | 2006-11-02 | 2012-09-25 | Curis, Inc. | Small organic molecule regulators of cell proliferation |
| WO2008076556A2 (en) | 2006-11-15 | 2008-06-26 | Massachusetts Eye & Ear Infirmary | Generation of inner ear cells |
| CA2673368C (en) | 2006-12-19 | 2014-10-28 | The Board Of Trustees Of The University Of Illinois | 3-benzofuranyl-4-indolyl maleimides as potent gsk3 inhibitors for neurogenerative disorders |
| WO2008115469A2 (en) | 2007-03-16 | 2008-09-25 | The Regents Of The University Of California | Role of hedgehog signaling in atherosclerosis and cardiovascular disease |
| DE102007021348A1 (de) | 2007-05-06 | 2008-11-20 | Universitätsklinikum Hamburg-Eppendorf (UKE) | Verfahren zur Simulation der Haptik einer Interaktion eines geführten Gegenstandes mit einem virtuellen dreidimensionalen Objekt |
| CA2690799C (en) | 2007-06-22 | 2015-06-16 | Arqule, Inc. | Pyrrolidinone, pyrrolidine-2,5-dione, pyrrolidine and thiosuccinimide derivatives, compositions and methods for treatment of cancer |
| DE102007032977A1 (de) | 2007-07-16 | 2009-01-22 | Universität Tübingen | Neue Cyclische Amide, Verfahren zu deren Herstellung und ihre Verwendung |
| WO2009017453A1 (en) | 2007-07-30 | 2009-02-05 | Astrazeneca Ab | New therapeutic combination of an antipsychotic and a gsk3 inhibitor 958 |
| WO2009017455A1 (en) | 2007-07-30 | 2009-02-05 | Astrazeneca Ab | A new combination of (a) an alpha-4-beta-2 -neuronal nicotinic agonist and (b) a gsk3 inhibitor |
| EP2197876A1 (en) | 2007-08-29 | 2010-06-23 | Glaxosmithkline LLC | Thiazole and oxazole kinase inhibitors |
| US8377886B2 (en) | 2007-09-14 | 2013-02-19 | Albert Einstein College Of Medicine Of Yeshiva University | Use of gamma secretase inhibitors and notch pathway inhibitors for treatment and prevention of renal disease |
| US9526737B2 (en) | 2007-12-03 | 2016-12-27 | The Regents Of The University Of California | Oxysterols for activation of hedgehog signaling, osteoinduction, antiadipogenesis, and Wnt signaling |
| AU2009205314A1 (en) | 2008-01-14 | 2009-07-23 | Foamix Ltd. | Poloxamer foamable pharmaceutical compositions with active agents and/or therapeutic cells and uses |
| JP5951254B2 (ja) | 2008-03-17 | 2016-07-13 | ザ スクリプス リサーチ インスティテュート | 人工多能性幹細胞を作製するための化学的手法と遺伝的手法の組み合わせ法 |
| WO2009132050A2 (en) | 2008-04-21 | 2009-10-29 | Otonomy, Inc. | Auris formulations for treating otic diseases and conditions |
| US20090270497A1 (en) | 2008-04-24 | 2009-10-29 | Pharmacyclics, Inc. | Treatment of Non-Localized Inflammation with pan-HDAC Inhibitors |
| WO2009142719A2 (en) | 2008-05-19 | 2009-11-26 | Massachusetts Institute Of Technology | Tympanic membrane permeating ear drops and uses thereof |
| US8496957B2 (en) | 2008-07-21 | 2013-07-30 | Otonomy, Inc | Controlled release auris sensory cell modulator compositions and methods for the treatment of otic disorders |
| US8298825B1 (en) | 2008-08-25 | 2012-10-30 | The General Hospital Corporation | TGF-beta receptor inhibitors to enhance direct reprogramming |
| US20120059021A1 (en) | 2008-11-11 | 2012-03-08 | University Of Washington | Compositions and methods for treating cancer and methods for predicting a response to such treatments |
| WO2010060088A2 (en) | 2008-11-24 | 2010-05-27 | Massachusetts Eye & Ear Infirmary | Pathways to generate hair cells |
| EP2376626A4 (en) | 2008-12-13 | 2012-10-17 | Dna Microarray | MICRO-ENVIRONMENTAL NICHE ASSAY FOR SCREENING OF INDUCED PLURIPOTENT STEM CELLS (CIPS) |
| US20130039998A1 (en) | 2008-12-24 | 2013-02-14 | University Of Washington | Compositions of modulators of the wnt/beta-catenin pathway and benzamide and/or hydroxamic acid derivatives to treat bipolar disorder |
| US9752124B2 (en) | 2009-02-03 | 2017-09-05 | Koninklijke Nederlandse Akademie Van Wetenschappen | Culture medium for epithelial stem cells and organoids comprising the stem cells |
| GB201111244D0 (en) | 2011-06-30 | 2011-08-17 | Konink Nl Akademie Van Wetenschappen Knaw | Culture media for stem cells |
| EP2412800A1 (en) | 2010-07-29 | 2012-02-01 | Koninklijke Nederlandse Akademie van Wetenschappen | Liver organoid, uses thereof and culture method for obtaining them |
| CA2755120C (en) | 2009-03-11 | 2017-05-16 | Kyorin Pharmaceutical Co., Ltd. | 7-cycloalkylaminoquinolones as gsk-3 inhibitors |
| EP2442802A1 (en) | 2009-06-17 | 2012-04-25 | Aderans Research Institute, Inc. | Methods and compositions for increasing trichogenic potency of dermal cells |
| WO2011019957A1 (en) | 2009-08-12 | 2011-02-17 | University Of Southern California | Method for formation of induced pluripotent stem cells |
| FR2955324A1 (fr) | 2010-01-15 | 2011-07-22 | Sanofi Aventis | [4-(5-aminomethyl-phenyl)-piperidin-1-yl]-1h-indol-3-yl]-methanones disubstituees |
| LT2494039T (lt) | 2009-10-31 | 2019-07-25 | Genesis Technologies Limited | Ląstelių perprogramavimo būdai ir jų panaudojimas |
| US20110135756A1 (en) | 2009-12-08 | 2011-06-09 | University Of Washington | Compositions and methods for protecting sensory hair cells |
| CA2785233C (en) | 2009-12-28 | 2018-10-09 | Audiocure Pharma Gmbh | .beta.-carbolines for treatment of hearing damages and vertigo |
| US8198285B2 (en) | 2010-01-19 | 2012-06-12 | Astrazeneca Ab | Pyrazine derivatives |
| WO2011109711A1 (en) | 2010-03-05 | 2011-09-09 | Duke University | Glucocorticoid drugs as smoothened agonists |
| WO2011116930A1 (en) | 2010-03-22 | 2011-09-29 | Cellartis Ab | Directed differentiation and maturation of pluripotent cells into hepatocyte like cells by modulation of wnt-signalling pathway |
| ES2705236T3 (es) | 2010-05-12 | 2019-03-22 | Univ Columbia | Procedimientos para producir células enteroendocrinas que producen y secretan insulina |
| EP3915367A1 (en) | 2010-08-18 | 2021-12-01 | BioSplice Therapeutics, Inc. | Diketones and hydroxyketones as catenin signaling pathway activators |
| WO2012024581A2 (en) | 2010-08-20 | 2012-02-23 | Fate Therapeutics, Inc. | Oxysterol compounds |
| WO2012024583A2 (en) | 2010-08-20 | 2012-02-23 | Fate Therapeutics, Inc. | Oxysterol compounds |
| WO2012024584A2 (en) | 2010-08-20 | 2012-02-23 | Fate Therapeutics, Inc. | Oxysterol compounds |
| CN103459591B (zh) | 2010-11-02 | 2016-05-04 | 国立大学法人熊本大学 | 肠细胞的制造方法 |
| FR2967498B1 (fr) | 2010-11-16 | 2015-01-02 | Centre Nat Rech Scient | Utilisation de derives de quinolinone comme outil de recherche |
| EP2667881A4 (en) | 2011-01-24 | 2015-04-22 | Univ Leland Stanford Junior | METHOD FOR IN VITRO GENERATION OF INTERNAL CELLS |
| WO2012115575A1 (en) | 2011-02-21 | 2012-08-30 | Biomatcell Ab | Derivatives for inducing osteogenic differentiation |
| CN102276615B (zh) * | 2011-08-26 | 2013-10-23 | 四川大学 | 一种制备甲酰阿地咪的方法 |
| HUE041576T2 (hu) | 2011-09-14 | 2019-05-28 | Samumed Llc | Indazol-3-karboxamid-származékok és alkalmazásuk Wnt/b-katenin szignalizáló útvonal inhibitorokként |
| EP2765188B1 (en) | 2011-10-06 | 2017-12-06 | Keio University | Method for producing corneal endothelial cell |
| EP2838888B1 (en) | 2012-02-24 | 2017-04-12 | ASD Therapeutics Partners LLC | Thiadiazolidinediones as gsk-3 inhibitors |
| US9457009B2 (en) | 2012-05-31 | 2016-10-04 | The United States Of America As Represented By The Department Of Veterans Affairs | Methods and compositions for preventing and treating auditory dysfunctions |
| US9499562B2 (en) * | 2012-06-18 | 2016-11-22 | Dart Neuroscience (Cayman) Ltd. | Substituted thiophene- and furan-fused azolopyrimidine-5-(6H)-one compounds |
| TW201406758A (zh) | 2012-06-28 | 2014-02-16 | Daiichi Sankyo Co Ltd | 三環性化合物 |
| GB201212960D0 (en) | 2012-07-20 | 2012-09-05 | Common Services Agency | Erythroid production |
| CA2884309A1 (en) | 2012-09-07 | 2014-03-13 | Massachusetts Eye And Ear Infirmary | Methods and compositions for regenerating hair cells and/or supporting cells from differentiated cochlear cells or differentiated utricular cells by modulation of notch and cmyc activity |
| WO2014050779A1 (ja) | 2012-09-25 | 2014-04-03 | 第一三共株式会社 | Gsk3阻害剤と抗dr5抗体の組み合わせ |
| DK2909204T3 (en) | 2012-10-12 | 2019-04-01 | Broad Inst Inc | GSK3 INHIBITORS AND METHODS FOR USE THEREOF |
| EP2925363A4 (en) | 2012-11-29 | 2016-11-09 | Strasspharma Llc | METHOD FOR MODULATING FOLLICLE-STIMULATING HORMONACTIVITY |
| CN105143445B (zh) | 2012-11-29 | 2020-07-07 | 宝生物欧洲公司 | 衍生自人多能干细胞的肝细胞样细胞的成熟 |
| US20140248696A1 (en) | 2013-03-01 | 2014-09-04 | Wisconsin Alumni Research Foundation | Methods of maintaining, expanding, and diffrentiating neuronal subtype specific progenitors |
| EP2964651A4 (en) | 2013-03-04 | 2016-11-30 | Brigham & Womens Hospital | BMP HEMMER AND METHOD OF USE THEREOF |
| BR112015023261A2 (pt) | 2013-03-14 | 2017-07-18 | Massachusetts Inst Technology | composições e métodos para expansão e cultura de células-tronco epiteliais |
| JP2016517888A (ja) | 2013-05-02 | 2016-06-20 | ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア | 骨選択的骨形成のオキシステロール骨標的薬剤 |
| AU2014302458A1 (en) * | 2013-06-26 | 2015-12-24 | Proteostasis Therapeutics, Inc. | Methods of modulating CFTR activity |
| WO2015168149A2 (en) | 2014-04-28 | 2015-11-05 | Massachusetts Eye & Ear Infirmary | Sensorineural hair cell differentiation |
| US10457915B2 (en) | 2014-05-15 | 2019-10-29 | International Stem Cell Corporation | Chemical differentiation of pluripotentstem cells into retinal epithelial cells |
| DK3206686T3 (da) | 2014-08-20 | 2019-12-16 | Samumed Llc | Gamma-diketoner til behandling og forebyggelse af ældning af huden og rynker |
| EP3201187A4 (en) | 2014-10-01 | 2018-04-11 | The Brigham and Women's Hospital, Inc. | Compositions and methods for inhibiting bmp |
| CA3010610A1 (en) | 2016-01-08 | 2017-07-13 | The Brigham And Women's Hospital, Inc. | Production of differentiated enteroendocrine cells and insulin producing cells |
| US9913848B2 (en) | 2016-03-02 | 2018-03-13 | Frequency Therapeutics, Inc. | Methods for controlled proliferation of stem cells / generating inner ear hair cells using 1,2,3,4-tetrahydro-[1,4]diazepino[6,7, 1-hi]indolyl based compounds |
| US10016507B2 (en) | 2016-03-02 | 2018-07-10 | Frequency Therapeutics, Inc. | Solubilized compositions for controlled proliferation of stem cells / generating inner ear hair cells using GSK3 inhibitors: III |
| US10383881B2 (en) | 2016-12-30 | 2019-08-20 | Frequency Therapeutics, Inc. | 1,5-dihydro-2H-pyrrol-2-one compounds and methods of using same |
| AU2017386417B2 (en) * | 2016-12-30 | 2022-07-14 | Frequency Therapeutics, Inc. | 1H-pyrrole-2,5-dione compounds and methods of using them to induce self-renewal of stem/progenitor supporting cells |
| AU2018250591A1 (en) * | 2017-04-11 | 2019-10-10 | Frequency Therapeutics, Inc. | Methods for hair follicle stem cell proliferation |
| WO2019126686A1 (en) | 2017-12-21 | 2019-06-27 | Frequency Therapeutics, Inc. | 1,2-dihydro-3h-pyrazol-3-one compounds and methods of using same |
| US20200316089A1 (en) | 2017-12-21 | 2020-10-08 | Frequency Therapeutics, Inc. | 1,2-dihydro-3h-pyrazol-3-one compounds and methods of using same |
-
2017
- 2017-12-21 AU AU2017386417A patent/AU2017386417B2/en not_active Ceased
- 2017-12-21 BR BR112019013388-7A patent/BR112019013388A2/pt not_active IP Right Cessation
- 2017-12-21 SG SG10201910821XA patent/SG10201910821XA/en unknown
- 2017-12-21 EP EP17829549.9A patent/EP3562827A1/en not_active Withdrawn
- 2017-12-21 US US16/474,220 patent/US11066419B2/en not_active Expired - Fee Related
- 2017-12-21 JP JP2019536012A patent/JP7109446B2/ja not_active Expired - Fee Related
- 2017-12-21 CN CN201780087768.9A patent/CN110392686A/zh active Pending
- 2017-12-21 CA CA3048220A patent/CA3048220A1/en active Pending
- 2017-12-21 MX MX2019007890A patent/MX390321B/es unknown
- 2017-12-21 KR KR1020197022347A patent/KR20190104359A/ko not_active Abandoned
- 2017-12-21 WO PCT/US2017/067885 patent/WO2018125746A1/en not_active Ceased
-
2019
- 2019-06-24 IL IL267601A patent/IL267601A/en unknown
-
2021
- 2021-06-03 US US17/337,516 patent/US20210300948A1/en not_active Abandoned
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2003076442A1 (en) | 2002-03-05 | 2003-09-18 | Eli Lilly And Company | Purine derivatives as kinase inhibitors |
| WO2009006043A2 (en) | 2007-07-02 | 2009-01-08 | Eli Lilly And Company | Potentiation of cancer chemotherapy by 7-(2,5-dihydro-4-imidazo [1,2-a]pyrine-3-yl-2,5-dioxo-ih-pyrrol-3-yl)-9-fluoro-1,2,3,4 tetrahydro-2-(1-piperidinyl-carbonyd-pyrrolo[3,2,1-jk][1,4]benzodiazepine |
| WO2013126805A2 (en) | 2012-02-24 | 2013-08-29 | Fate Therapeutics, Inc. | Small molecule compounds to treat hearing loss |
| WO2016037016A1 (en) | 2014-09-03 | 2016-03-10 | The Brigham And Women's Hospital, Inc. | Compositions, systems, and methods for generating inner ear hair cells for treatment of hearing loss |
Non-Patent Citations (1)
| Title |
|---|
| CAS REGISTRY NO. 1222786-29-9,DATABASE REGISTRY, [online],2010年05月13日,[2021.11.12検索], Retrieved from: STN |
Also Published As
| Publication number | Publication date |
|---|---|
| CN110392686A (zh) | 2019-10-29 |
| CA3048220A1 (en) | 2018-07-05 |
| MX390321B (es) | 2025-03-20 |
| JP2020503340A (ja) | 2020-01-30 |
| AU2017386417A1 (en) | 2019-07-11 |
| WO2018125746A1 (en) | 2018-07-05 |
| US11066419B2 (en) | 2021-07-20 |
| SG10201910821XA (en) | 2020-01-30 |
| US20210300948A1 (en) | 2021-09-30 |
| MX2019007890A (es) | 2020-01-20 |
| IL267601A (en) | 2019-08-29 |
| KR20190104359A (ko) | 2019-09-09 |
| US20190352313A1 (en) | 2019-11-21 |
| BR112019013388A2 (pt) | 2020-03-03 |
| AU2017386417B2 (en) | 2022-07-14 |
| EP3562827A1 (en) | 2019-11-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2020503340A (ja) | 幹細胞/前駆支持細胞の自己複製を誘導するための1h−ピロール−2,5−ジオン化合物およびその使用方法 | |
| US10383881B2 (en) | 1,5-dihydro-2H-pyrrol-2-one compounds and methods of using same | |
| JP7023820B2 (ja) | 多分化能細胞および多能性細胞の分化を方向付けることによって発生させる皮質介在ニューロンおよびその他のニューロン細胞 | |
| JP2022048143A (ja) | 分化した腸内分泌細胞およびインスリン産生細胞の作製 | |
| US20210189349A1 (en) | Esophageal tissue and/or organoid compositions and methods of making same | |
| JP2019507802A (ja) | GSK3α阻害剤を用いる、幹細胞の制御された増殖/内耳有毛細胞の発生のための方法 | |
| JP2020516282A (ja) | 毛包幹細胞増殖のための方法 | |
| AU2023201216A1 (en) | Methods for controlled proliferation of vestibular stem cells / generating inner ear hair cells using wnt and tgf-beta inhibition | |
| TW202200786A (zh) | 自肺上皮細胞或肺癌細胞製造類器官之方法 | |
| JPWO2020040166A1 (ja) | 腸管神経前駆細胞の製造方法 | |
| US20200121681A1 (en) | Methods for hair follicle stem cell proliferation | |
| CN117751182A (zh) | 用于扩增人粒细胞-巨噬细胞祖细胞的方法及其应用 | |
| US10220041B2 (en) | Methods for controlled proliferation of stem cells / generating inner ear hair cells using 3-(pyridin-2-yl)-1H-indol-2-ol based compounds | |
| US9913848B2 (en) | Methods for controlled proliferation of stem cells / generating inner ear hair cells using 1,2,3,4-tetrahydro-[1,4]diazepino[6,7, 1-hi]indolyl based compounds | |
| WO2019126686A1 (en) | 1,2-dihydro-3h-pyrazol-3-one compounds and methods of using same | |
| US9913835B2 (en) | Methods for controlled proliferation of stem cells / generating inner ear hair cells using N-(alkylcarbamoyl)-1H-pyrazol-4-yl)-nicotinamide based compounds | |
| US20200316089A1 (en) | 1,2-dihydro-3h-pyrazol-3-one compounds and methods of using same | |
| WO2023054396A1 (ja) | 下垂体組織を含む細胞集団の製造方法及びその細胞集団 | |
| CN115975938A (zh) | 胃癌原代细胞的培养基和培养方法 | |
| CN115960832A (zh) | 一种肠癌原代细胞的培养基及体外培养方法和用途 | |
| US20170252339A1 (en) | Methods for controlled proliferation of stem cells / generating inner ear hair cells using 2-pyrimidinylaminoethylamino-2-pyridyl based compounds | |
| WO2026039202A1 (en) | Enteroids and organoids derived in vitro from pluripotent stem cells, and uses thereof | |
| Da Silva | Therapeutic Impairment of Acinar Ductal Metaplasia in Murine Pancreatic Three-Dimensional Organoids | |
| EA047959B1 (ru) | Способ получения энтеральных нейральных клеток-предшественников |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20190819 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20201215 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20201215 |
|
| RD04 | Notification of resignation of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7424 Effective date: 20210331 |
|
| A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20211111 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20211208 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20220307 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20220607 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20220620 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20220719 |
|
| R150 | Certificate of patent or registration of utility model |
Ref document number: 7109446 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
| LAPS | Cancellation because of no payment of annual fees |